Activation of TLR4 leads to downstream release of inflammatory modulators including TNF-α, IL-1β and MCP-1[33].Moreover, previous studies demonstrated that inflammation plays a crucial role in the pathogenesis of hypertension, and the development and progression of renalfibrosis[13,34]. Here, TLR4 is linked to hypertensive disorder.